Targets of the Tumor Suppressor miR-200 in Regulation of the Epithelial-Mesenchymal Transition in Cancer

Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Cancer Research (Impact Factor: 9.28). 12/2011; 71(24):7670-82. DOI: 10.1158/0008-5472.CAN-11-0964
Source: PubMed

ABSTRACT The microRNA-200 (miR-200) family restricts epithelial-mesenchymal transition (EMT) and metastasis in tumor cell lines derived from mice that develop metastatic lung adenocarcinoma. To determine the mechanisms responsible for EMT and metastasis regulated by this microRNA, we conducted a global liquid chromatography/tandem mass spectrometry analysis to compare metastatic and nonmetastatic murine lung adenocarcinoma cells which had undergone EMT because of loss of miR-200. An analysis of syngeneic tumors generated by these cells identified multiple novel proteins linked to metastasis. In particular, the analysis of conditioned media, cell surface proteins, and whole-cell lysates from metastatic and nonmetastatic cells revealed large-scale modifications in the tumor microenvironment. Specific increases were documented in extracellular matrix (ECM) proteins, peptidases, and changes in distribution of cell adhesion proteins in the metastatic cell lines. Integrating proteomic data from three subproteomes, we defined constituents of a multilayer protein network that both regulated and mediated the effects of TGFβ. Lastly, we identified ECM proteins and peptidases that were directly regulated by miR-200. Taken together, our results reveal how expression of miR-200 alters the tumor microenvironment to inhibit the processes of EMT and metastasis.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Small non-coding microRNAs have emerged as important regulators of cellular processes, but their role in pancreatic beta cells has only started to be elucidated. Loss of pancreatic beta cells is a key factor in the pathogenesis of diabetes and we have demonstrated that beta cell expression of thioredoxin-interacting protein (TXNIP) is increased in diabetes and causes beta cell apoptosis, whereas TXNIP deficiency is protective against diabetes. Recently, we found that TXNIP also impairs beta cell function by inducing microRNA-204. Interestingly, using INS-1 beta cells as well as primary islets we now discovered that expression of another microRNA, miR-200, was induced by TXNIP and by diabetes. Furthermore, we found that miR-200 targeted and decreased Zinc Finger E-Box Binding Homeobox 1 (Zeb1) and promoted beta cell apoptosis as measured by cleaved caspase-3 levels, Bax/Bcl2 ratio, and TUNEL. In addition, Zeb1 knockdown was able to mimic the miR-200 effects on beta cell apoptosis suggesting that Zeb1 plays an important role in mediating the miR-200 effects. Moreover, miR-200 increased beta cell expression of the epithelial marker E-cadherin consistent with inhibition of epithelial-mesenchymal-transition (EMT), a process thought to be involved in beta cell expansion. Thus, we have identified a novel TXNIP-miR-200-Zeb1-E-cadherin signaling pathway that for the first time ties miR-200 to beta cell apoptosis and diabetes and links beta cell TXNIP to EMT. In addition, the present studies shed new light on the regulation and function of miR-200 in beta cells and demonstrate that TXNIP-induced microRNAs control various processes of beta cell biology.
    Journal of Biological Chemistry 11/2014; 289(52). DOI:10.1074/jbc.M114.592360 · 4.60 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Radioresistance remains a major problem in the treatment of patients suffering from nasopharyngeal carcinoma (NPC). A better understanding of the mechanisms involved in the induction of radioresistance may provide strategies to improve NPC patients' response to therapy. The present study aimed to investigate the effect of microRNA (miR)-101 on the radioresistance of NPC cells. Analysis of miR-101 expression levels indicated that miR-101 was downregulated in NPC cell lines. Furthermore, ectopic expression of miR-101 suppressed cell proliferation and enhanced radiosensitivity of NPC cells. Stathmin 1 (STMN1) was additionally verified as a direct functional target of miR-101, which was found to be involved in cell viability, radioresistance and radiation-induced autophagy of NPC cells. In conclusions, the results of the present study suggested that the identified miR-101/STMN1 pathway contributed to the elucidation of the mechanisms of radioresistance in human NPC and that it may represent a potential therapeutic target.
    Molecular Medicine Reports 01/2015; DOI:10.3892/mmr.2015.3221 · 1.48 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Each year about 1.4 million people die from lung cancer worldwide. Despite efforts in prevention, diagnosis and treatment, survival rate remains poor for this disease. This unfortunate situation is largely due to the fact that a high proportion of cases are diagnosed at advanced stages, highlighting the great need for identifying new biomarkers in order to improve early diagnosis and treatment. Recent studies on microRNAs have not only shed light on their involvement in tumor development and progression, but also suggested their potential utility as biomarkers for subtype diagnostics, staging and prediction of treatment response. This review article summarizes the impact of microRNAs on lung cancer biology, and highlights their role in the detection and classification of lung cancer as well as direct targets for drug development.
    03/2012; 2(3):1000108. DOI:10.4172/2153-0769.1000108

Full-text (2 Sources)

Available from
May 26, 2014